Which ETFs hold Bristol-Myers Squibb Co (BMY)?
American pharmaceutical company focused on cancer, heart and immune system medicines.
47 Australian ETFs hold Bristol-Myers Squibb Co, a Health Care company from United States. ZYUS has the biggest weighting at 2.06%. Across these funds, Australian ETF investors own about $259m of Bristol-Myers Squibb Co.
The ETFs with the most Bristol-Myers Squibb Co
All 47 ETFs that hold Bristol-Myers Squibb Co, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Bristol-Myers Squibb Co.
Common questions
Which ETF has the most Bristol-Myers Squibb Co?
ZYUS (Global X S&P 500 High Yield Low Volatility ETF) has the highest weighting, with 2.06% of the fund in Bristol-Myers Squibb Co.
What is the cheapest ETF that holds Bristol-Myers Squibb Co?
Of the ETFs where Bristol-Myers Squibb Co is at least 1% of the fund, ZYUS has the lowest fee at 0.35% a year, with 2.06% in Bristol-Myers Squibb Co.
How much Bristol-Myers Squibb Co do I own with $10,000 in VGS?
About $14. VGS is the largest ETF that holds Bristol-Myers Squibb Co, and Bristol-Myers Squibb Co makes up 0.14% of it.
How many Australian ETFs hold Bristol-Myers Squibb Co?
47 ETFs listed on the ASX or TMX Australia hold Bristol-Myers Squibb Co, based on issuers' published holdings.